MSD
Pembrolizumab
Biodrugs/ Drugs
Cancer
Trastuzumab + Chemotherapy with or without Pembrolizumab as First-line Treatment in Participants With HER2 Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
3Phase III in Spain,
2Phase II,
1Phase I